Drug Shortage Report for ARICEPT
| Report ID | 229720 |
| Drug Identification Number | 02232043 |
| Brand name | ARICEPT |
| Common or Proper name | Aricept 5mg |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | DONEPEZIL HYDROCHLORIDE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 1x30 |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-05-31 |
| Estimated end date | 2024-10-31 |
| Actual end date | 2024-10-29 |
| Shortage status | Resolved |
| Updated date | 2024-10-30 |
| Company comments | Aricept 10m remains fully available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2024-06-05 | English | Compare |
| v2 | 2024-06-05 | English | Compare |
| v3 | 2024-06-05 | French | Compare |
| v4 | 2024-10-03 | English | Compare |
| v5 | 2024-10-03 | French | Compare |
| v6 | 2024-10-30 | English | Compare |
| v7 | 2024-10-30 | French | Compare |
Showing 1 to 7 of 7